1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Antiseptic and Disinfectant Market
4. Market Overview
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Antiseptic and Disinfectant Market Analysis and Forecast, 2023-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. List of Antiseptics and Disinfectants Used for Sanitization
5.3. Disease Prevalence & Incidence Rate Globally with Key Countries
5.4. COVID-19 Pandemic Impact on Industry
6. Global Antiseptic and Disinfectant Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2023-2031
6.3.1. Quaternary Ammonium Compounds
6.3.2. Chlorine Compounds
6.3.3. Alcohols
6.3.4. Aldehydes
6.3.5. Phenolic Compounds
6.3.6. Hydrogen Peroxide
6.3.7. Iodine
6.3.8. Silver
6.3.9. Others
6.4. Market Attractiveness, by Product
7. Global Antiseptic and Disinfectant Market Analysis and Forecast, by End-user
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2023-2031
7.3.1. Healthcare Providers
7.3.2. Commercial Users
7.3.3. Domestic Users
7.4. Market Attractiveness, by End-user
8. Global Antiseptic and Disinfectant Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2023-2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Region
9. North America Antiseptic and Disinfectant Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2023-2031
9.2.1. Quaternary Ammonium Compounds
9.2.2. Chlorine Compounds
9.2.3. Alcohols
9.2.4. Aldehydes
9.2.5. Phenolic Compounds
9.2.6. Hydrogen Peroxide
9.2.7. Iodine
9.2.8. Silver
9.2.9. Others
9.3. Market Value Forecast, by End-user, 2023-2031
9.3.1. Healthcare Providers
9.3.2. Commercial Users
9.3.3. Domestic Users
9.4. Market Value Forecast, by Country, 2023-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Antiseptic and Disinfectant Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2023-2031
10.2.1. Quaternary Ammonium Compounds
10.2.2. Chlorine Compounds
10.2.3. Alcohols
10.2.4. Aldehydes
10.2.5. Phenolic Compounds
10.2.6. Hydrogen Peroxide
10.2.7. Iodine
10.2.8. Silver
10.2.9. Others
10.3. Market Value Forecast, by End-user, 2023-2031
10.3.1. Healthcare Providers
10.3.2. Commercial Users
10.3.3. Domestic Users
10.4. Market Value Forecast, by Country/Sub-region, 2023-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Antiseptic and Disinfectant Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2023-2031
11.2.1. Quaternary Ammonium Compounds
11.2.2. Chlorine Compounds
11.2.3. Alcohols
11.2.4. Aldehydes
11.2.5. Phenolic Compounds
11.2.6. Hydrogen Peroxide
11.2.7. Iodine
11.2.8. Silver
11.2.9. Others
11.3. Market Value Forecast, by End-user, 2023-2031
11.3.1. Healthcare Providers
11.3.2. Commercial Users
11.3.3. Domestic Users
11.4. Market Value Forecast, by Country/Sub-region, 2023-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Antiseptic and Disinfectant Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2023-2031
12.2.1. Quaternary Ammonium Compounds
12.2.2. Chlorine Compounds
12.2.3. Alcohols
12.2.4. Aldehydes
12.2.5. Phenolic Compounds
12.2.6. Hydrogen Peroxide
12.2.7. Iodine
12.2.8. Silver
12.2.9. Others
12.3. Market Value Forecast, by End-user, 2023-2031
12.3.1. Healthcare Providers
12.3.2. Commercial Users
12.3.3. Domestic Users
12.4. Market Value Forecast, by Country/Sub-region, 2023-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Antiseptic and Disinfectant Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2023-2031
13.2.1. Quaternary Ammonium Compounds
13.2.2. Chlorine Compounds
13.2.3. Alcohols
13.2.4. Aldehydes
13.2.5. Phenolic Compounds
13.2.6. Hydrogen Peroxide
13.2.7. Iodine
13.2.8. Silver
13.2.9. Others
13.3. Market Value Forecast, by End-user, 2023-2031
13.3.1. Healthcare Providers
13.3.2. Commercial Users
13.3.3. Domestic Users
13.4. Market Value Forecast, by Country/Sub-region, 2023-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Novartis AG
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. 3M
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Johnson & Johnson
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. STERIS plc
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Getinge Group
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Cardinal Health
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. BD
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Whiteley Corporation
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Kimberly-Clark
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
